Hunneman Facilitates Closing of Swiss Drug Delivery Device Maker’s First U.S. Manufacturing Facility
Ypsomed buys 160,000 square-foot building in North Carolina with an option for further expansion.
HOLLY SPRINGS, NORTH CAROLINA (February 11, 2026) – Hunneman, New England’s premier, full-service commercial real estate provider, announced that it has facilitated the closing of a new U.S. manufacturing site for Swiss company Ypsomed, a leading developer and manufacturer of injection systems for the self-administration of liquid medication. Located in Holly Springs, North Carolina, the 160,000 square-foot facility will be Ypsomed’s first manufacturing site in North America and includes an option for further expansion.
“For nearly three years, we worked closely with Ypsomed and their partners to identify the most favorable, sustainable, and accessible location for their first significant business expansion in North America,” said Jim Boudrot, Executive Vice President at Hunneman. “This new facility will allow Ypsomed to continue to attract and retain exceptional talent while establishing their operations in the country. We’ve appreciated the collaboration with CBRE, the local city officials, and the North Carolina government, whose enthusiasm and support were paramount in securing this site in Holly Springs for Ypsomed.”
Ypsomed’s new manufacturing site is located at THE YIELD Holly Springs, a premier life science and innovative manufacturing campus in North Carolina’s Research Triangle. THE YIELD is comprised of a 150-acre campus for manufacturing and nearly two million square feet of biomanufacturing, office, lab, and retail space. Ypsomed’s manufacturing facility, located at Building H of the campus, will supply products for the U.S. market and integrate all phases of the supply chain, spanning research and development, manufacturing, fill/finish, and delivery.
The site plans to begin supplying products in the United States market by the end of 2027. THE YIELD also offers a tremendous expansion opportunity for Ypsomed to grow with adjacent land parcels available
“Establishing our new production site in the United States marks an important step in Ypsomed’s global growth strategy. We have deliberately chosen Holly Springs, a location at the heart of our industry, close to our customers. The cooperative approach of the local authorities, the excellent infrastructure, and the proximity to top-tier universities provide ideal conditions for our future growth,” said Simon Michel, CEO of Ypsomed. “This environment will allow us to attract the skilled workforce we need and to further strengthen our position as a leading supplier of self-injection systems worldwide, while contributing to the security of supply for the U.S. healthcare market.”
Onsite and adjacent amenities of the facility include a one-acre park, open space walking trails, and accessible retail. THE YIELD Holly Springs is located across from Oakview Commons, providing tenants with direct access to 50,000 square feet of shops and restaurants. The site is also a convenient 20-minute drive from Raleigh-Durham International Airport.
The location is adjacent to corporate neighbors including FujiFilm Biotechnology, CSL Seqirus, and Amgen, and offers proximity to top research universities in the area including Duke University, UNC-Chapel Hill, and NC State.
Ypsomed’s North American search was represented by Hunneman’s Leasing & Advisory team of Steve James and Jim Boudrot in this closing, and locally represented in the Research Triangle by CBRE.
About Hunneman
Hunneman is New England’s premier, full-service commercial real estate provider. Since 1929, Hunneman has supplied leasing and advisory, property management, appraisal and consulting, capital markets, investment sales, and research and marketing services to its broad portfolio of clients throughout New England With over 16 million square feet of office, industrial, flex, multifamily, and retail properties under management, and $4.0 billion in sales across over 800 transactions, Hunneman is the largest independently owned firm in Boston. For more information and updates on Hunneman, visit www.hunnemanre.com, or follow along on LinkedIn, Instagram, X (formerly known as Twitter), and Facebook.
Media Contact
Julianne Hester
jhester@issuesgroup.com
(857) 319-8595
